CMS introduces new ACO model for payment and care delivery reform

The Centers for Medicare & Medicaid Services (CMS) announced an updated model of accountable care organization (ACO) that focuses on new payment and care delivery models.

Previously, CMS had introduced the Pioneer ACO model and the Medicare Shared Savings program. CMS said participants in the Next Generation ACO model will have more performance risk but can share in more savings than the earlier models.

Organizations can apply to participate in the Next Generation ACO model in 2015 and 2016. They will have up to a five-year commitment.

According to CMS, the new ACO model will lead to better coordination between providers and patients.

“The Next Generation ACO Model is one of many innovative payment and care delivery models created under the Affordable Care Act, and is an important step towards advancing models of care that reward value over volume in care delivery,” Department of Health and Human Services Secretary Sylvia M. Burwell said in a news release. “This model is part of our larger effort to set clear, measurable goals and a timeline to move the Medicare program--and the healthcare system at large--toward paying providers based on the quality, rather than the quantity of care they give patients.”

Read the news release here.

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.